PegBio

Recent Articles

RELATED ARTICLES

  1. The developer of treatments for cancer and bone fractures is branching out into the weight-loss market, but faces strong competition there.
    Jiuyuan Gene seeks IPO cash for bet on weight-loss drugs
  2. Facing revenue crisis, Ascletis Pharma tries to bulk up with obesity drugs
    1672.HK
  3. Innovent Bio hopes for plus-sized profits from obesity drug
    1801.HK
  4. Novel drugs lift Sino Biopharm earnings, easing price-cap pain
    1177.HK
  5. CSPC Pharma weighs up diet drug for bigger bottom line
    1093.HK
  6. CSPC Pharma taps R&D superstar in quest for new breakout drugs
    1093.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva